The Business Research Company’s report on the Digestive and Intestinal Remedies Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
Which emerging drivers are set to accelerate the growth of the digestive and intestinal remedies market further?
The increase in gastrointestinal disorder cases is expected to propel the digestive and intestinal remedy market going forward. Gastrointestinal disorders refer to a collective term of diseases such as nausea, vomiting, food poisoning, and diarrhea that impact the overall biological functioning of the gastrointestinal (GI) tract. The rising incidence of gastrointestinal disorders has resulted in a growing demand for digestive and intestinal remedies that can treat gastrointestinal diseases effectively. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization, approximately 26,890 new cases of stomach cancer are anticipated in the U.S. in 2024, with 16,160 cases in men and 10,730 in women. It is also expected that this type of cancer will lead to about 10,880 deaths, comprising 6,490 men and 4,390 women. Therefore, an increase in gastrointestinal disorder cases is expected to drive the growth of the digestive and intestinal remedy market.
Access Your Free Sample of the Global Digestive and Intestinal Remedies Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8184&type=smp
What are the key factors influencing the forecasted market size of the digestive and intestinal remedies industry?
The digestive and intestinal remedies market size has grown strongly in recent years. It will grow from $21.37 billion in 2024 to $22.5 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to traditional remedies, lifestyle changes, increased stress levels, dietary shifts, and COVID-19 impact.
The digestive and intestinal remedies market size is expected to see strong growth in the next few years. It will grow to $29.16 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to healthcare accessibility, global health events, rising health consciousness, ageing population, innovative product development. Major trends in the forecast period include healthcare access, environmental factors, consumer education, regulatory environment, pharmaceutical advancements.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8184&type=smp
Who are the leading competitors in the digestive and intestinal remedies market?
Major companies operating in the digestive and intestinal remedies market are Bayer AG, Abbott Laboratories, Bausch Health Companies Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Jiangzhong Pharmaceutical Co. Ltd., Johnson & Johnson Pvt. Ltd., Menarini Group, Merck Co. & KGaA, Pfizer Inc., Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited, AbbVie Inc., Alfa Wassermann and Sigma-Tau, Allergan PLC, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Daiichi Sankyo Chemical Pharma Co. Ltd., Evoke Pharma Inc., Ipsen SA, Ironwood Pharmaceuticals Inc., Mundipharma, Mylan NV, Norgine Pharmaceuticals Ltd., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Perrigo Company, Recordati S.p.A., RedHill Biopharma Ltd., Ritter Pharmaceuticals Inc., Salix Pharmaceuticals Inc.
Which emerging trends are set to transform the digestive and intestinal remedies market landscape?
Technological developments and advancements are key trend gaining popularity in the digestive and intestinal remedy market. Major players operating in the digestive and intestinal remedy market are focused on creating innovative technologies to manage and monitor digestive health in the digestive and intestinal remedy market. Recently the market has witnessed the use of breath analyzers to gather clinical condition information related to the digestive system. For instance, in February 2022, FoodMarble, an Ireland-based company that offers breath testing devices, launched the AIRE 2 digestive breath tester. FoodMarble has introduced a pocket-sized device that allows individuals with digestive issues like SIBO (Small Intestinal Bacterial Overgrowth) and IBS to measure and monitor their digestion in real time, helping them better manage their health. This advanced technology identifies foods that contribute to rapid fermentation in the gut, which can trigger various digestive symptoms. The device is also designed for use by healthcare professionals to gain deeper insights into patients’ digestive disorders, including IBS and SIBO.
How do different geographies compare in terms of market share and growth potential in the digestive and intestinal remedies market?
North America was the largest region in the digestive and intestinal remedies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digestive and intestinal remedies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
Which major segments of the digestive and intestinal remedies market are experiencing the fastest growth?
The digestive and intestinal remedies market covered in this report is segmented –
1) By Type: Digestive Medicines, Remedies Against Gastrointestinal Complaints, Natural And Synthetic Agents
2) By Age Group: Pediatric, Adults
3) By Distribution Channel: Online, Offline
Subsegments:
1) By Digestive Medicines: Antacids, Digestive Enzymes, Proton Pump Inhibitors (PPIs), H2-Receptor Antagonists
2) By Remedies Against Gastrointestinal Complaints: Anti-Nausea Medications, Antidiarrheal Agents, Laxatives, Gastroprotective Agents
3) By Natural And Synthetic Agents: Herbal Remedies, Synthetic Antispasmodics, Probiotics And Prebiotics
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8184
What defines the structure and scope of the digestive and intestinal remedies market?
The digestive and intestinal remedy refers to medications that can treat gastrointestinal disorders such as stomach upset, constipation, and diarrhea. It uses classes of drugs such as antacids, proton pump inhibitors, and histamine2 blockers during the treatment process.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
